Correlation Between Pharmagreen Biotech and Auxly Cannabis

Can any of the company-specific risk be diversified away by investing in both Pharmagreen Biotech and Auxly Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmagreen Biotech and Auxly Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmagreen Biotech and Auxly Cannabis Group, you can compare the effects of market volatilities on Pharmagreen Biotech and Auxly Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmagreen Biotech with a short position of Auxly Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmagreen Biotech and Auxly Cannabis.

Diversification Opportunities for Pharmagreen Biotech and Auxly Cannabis

0.37

Correlation Coefficient

Pharmagreen Biotech  Auxly Cannabis

Weak diversification

The 3 months correlation between Pharmagreen and Auxly is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Pharmagreen Biotech and Auxly Cannabis Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Auxly Cannabis Group and Pharmagreen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmagreen Biotech are associated (or correlated) with Auxly Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Auxly Cannabis Group has no effect on the direction of Pharmagreen Biotech i.e., Pharmagreen Biotech and Auxly Cannabis go up and down completely randomly.

Pair Corralation between Pharmagreen Biotech and Auxly Cannabis

Given the investment horizon of 90 days Pharmagreen Biotech is expected to generate 13.29 times less return on investment than Auxly Cannabis. In addition to that, Pharmagreen Biotech is 1.05 times more volatile than Auxly Cannabis Group. It trades about 0.03 of its total potential returns per unit of risk. Auxly Cannabis Group is currently generating about 0.48 per unit of volatility. If you would invest  2.00  in Auxly Cannabis Group on October 23, 2024 and sell it today you would earn a total of  1.50  from holding Auxly Cannabis Group or generate 75.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pharmagreen Biotech  vs.  Auxly Cannabis Group

Pharmagreen Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharmagreen Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Auxly Cannabis Group

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Auxly Cannabis Group are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Auxly Cannabis reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharmagreen Biotech and Auxly Cannabis

The main advantage of trading using opposite Pharmagreen Biotech and Auxly Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmagreen Biotech position performs unexpectedly, Auxly Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Auxly Cannabis will offset losses from the drop in Auxly Cannabis' long position.

The idea behind Pharmagreen Biotech and Auxly Cannabis Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.